• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsVerona Pharma
    Picture of Verona Pharma logo

    VRNA — Verona Pharma News Story

    $106.790.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    • Market Cap
      $9.09bn
    • Enterprise Value
      $8.90bn
    • Revenue
      $42.28m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • VRNA Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    VRNA Dividends
    All News

    NASDAQ RESUMED AT 02:53 PM

    Picture of Verona Pharma logoVerona Pharma
    26/02/2020 19:53
    NASDAQ RESUMED  VRNA.O  AT 02:53 PM
    

    Recent news on Verona Pharma

    See all news
    • Brief: Acquisition Of Verona By Msd Approved By The High Court Of Justice Of England And Wales

      06/10/2025 23:53
    • Brief: Shareholders Of Verona Pharma Approve Proposed Acquisition By Merck

      24/09/2025 23:16
    • US corporate debt market returns in force after market holiday

      03/09/2025 15:20
    • Merck to cut jobs and costs as demand for Gardasil in China remains weak (updated)

      29/07/2025 11:58
    • Merck to cut jobs and costs as demand for Gardasil in China remains weak

      29/07/2025 11:30

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.